<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82693">
  <stage>Registered</stage>
  <submitdate>27/03/2008</submitdate>
  <approvaldate>31/03/2008</approvaldate>
  <actrnumber>ACTRN12608000152325</actrnumber>
  <trial_identification>
    <studytitle>Near infrared laser confocal endomicroscopy of the human liver.</studytitle>
    <scientifictitle>Patients with known or suspected liver disease who are indicated for laparoscopic liver biopsy undergo near infrared confocal imaging, to assess the feasibility and diagnostic potential of in vivo confocal images compared with conventional histopathological analysis of liver biopsy tissue.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Liver disease: fibrosis, cirrhosis, steatosis, inflammation</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Other inflammatory or immune system disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>All patients in the study will undergo standard mini-laparoscopy plus near infrared confocal endomicroscopy. In vivo microscopic imaging using an intravenously administered fluorescent contrast agent (Indocyanine Green 0.5%) is performed by placing the rigid imaging probe in contact with the liver during the participant's routine mini-laparoscopy procedure. Endomicroscopy is expected to add 5-10 minutes to each participant's mini-laparoscopy procedure (1 session per participant).</interventions>
    <comparator>The standard laparoscopy procedure undergone by all subjects will involve liver biopsy, which will act as the control diagnostic procedure. The liver biopsy will be performed immediately after endomicroscopic imaging to provide conventional histopathological diagnosis of cellular and architecture features and liver disease status.</comparator>
    <control>Active</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Endomicroscopy images from the liver</outcome>
      <timepoint>During mini-laparoscopy approximately 30-40 images will be collected from each imaging site to document the surface and subsurface cellular structure of the liver.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Conventional histology from the liver biopsy</outcome>
      <timepoint>Histopathological anaylsis of each liver biopsy will be available from pathology approximately 1 week post mini-laparoscopy.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Accuracy of endomicroscopy for predicting histology based on a simple image classification system</outcome>
      <timepoint>Predictions of histology will be made  immediately after confocal images of the liver are obtained, and before conventional histology results are known.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients indicated for laparoscopic liver assessment as determined by the attending hepatologist, age &gt;18 years, a negative pregnancy test, written informed consent.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients under the age of 18 years. 
Patients with blood coagulation disorders (Quick's test &lt;50%; PTT&gt;50s; platelets &lt;50.000/nl), impaired renal function (serum creatinine &gt;1.2mg/dl), lack of liver visualisation by ultrasonography, uncontrolled ascites or hyperthyreosis.
Patients unable to give informed consent. Women who are pregnant or breast-feeding.
Patients with known allergy or prior adverse reaction to Indocyanine Green.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>25/03/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Germany</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Optiscan Pty Ltd</primarysponsorname>
    <primarysponsoraddress>15-17 Normanby Road
Notting Hill Victoria 3168</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Optiscan Pty Ltd</fundingname>
      <fundingaddress>15-17 Normanby Road
Notting Hill Victoria 3168</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study aims to evaluate the diagnostic accuracy of a near infrared confocal imaging device for identifying the cellular and architectural features of liver disease during mini-laparoscopy.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethics Committee of Rheinland-Pfalz</ethicname>
      <ethicaddress />
      <ethicapprovaldate>22/02/2008</ethicapprovaldate>
      <hrec>837.019.06 (5116)</hrec>
      <ethicsubmitdate />
      <ethiccountry>Germany</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Martin Goetz</name>
      <address>I. Medizinische Klinik und Poliklinik
Universit√§tsklinik Mainz
Langenbeckstr 1
D-55131 Mainz</address>
      <phone>0049 6131171</phone>
      <fax>0049 6131173438</fax>
      <email>mgoetz@uni-mainz.de</email>
      <country>Germany</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Elise Murr</name>
      <address>15-17 Normanby Road
Notting Hill Victoria 3168</address>
      <phone>+61 3 95383333</phone>
      <fax>+61 3 95627742</fax>
      <email>elisem@optiscan.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Elise Murr</name>
      <address>15-17 Normanby Road
Notting Hill Victoria 3168</address>
      <phone>+61 3 95383333</phone>
      <fax>+61 3 95627742</fax>
      <email>elisem@optiscan.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>